{"id":"https://openalex.org/W1989339737","doi":"https://doi.org/10.1182/blood-2013-02-485441","title":"Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma","display_name":"Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma","publication_year":2013,"publication_date":"2013-08-03","ids":{"openalex":"https://openalex.org/W1989339737","doi":"https://doi.org/10.1182/blood-2013-02-485441","mag":"1989339737","pmid":"https://pubmed.ncbi.nlm.nih.gov/23913470"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2013-02-485441","doi":"https://doi.org/10.1182/blood-2013-02-485441","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2013-02-485441","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer E. Amengual","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022554119","display_name":"Sean Clark-Garvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Clark-Garvey","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053153501","display_name":"Matko Kalac","orcid":"https://orcid.org/0000-0003-1238-0760","observed_orcids":["https://orcid.org/0000-0003-1238-0760"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matko Kalac","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016848239","display_name":"Luigi Scotto","orcid":"https://orcid.org/0000-0002-7071-926X","observed_orcids":["https://orcid.org/0000-0002-7071-926X"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luigi Scotto","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102738050","display_name":"Enrica Marchi","orcid":"https://orcid.org/0000-0002-6661-9119","observed_orcids":["https://orcid.org/0000-0002-6661-9119"]},"institutions":[{"id":"https://openalex.org/I1281027232","display_name":"Lincoln Medical Center","ror":"https://ror.org/035a72598","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1281027232","https://openalex.org/I1283621791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrica Marchi","raw_affiliation_strings":["Department of Medicine, Lincoln Medical Center, New York, NY; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Lincoln Medical Center, New York, NY; and","institution_ids":["https://openalex.org/I1281027232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031311239","display_name":"Ellen Neylon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen Neylon","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012068982","display_name":"Paul M. Johannet","orcid":"https://orcid.org/0000-0002-9264-8327","observed_orcids":["https://orcid.org/0000-0002-9264-8327"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Johannet","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055029890","display_name":"Ying Wei","orcid":"https://orcid.org/0000-0002-7164-8109","observed_orcids":["https://orcid.org/0000-0002-7164-8109"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Wei","raw_affiliation_strings":["Mailman School of Public Health, Columbia University, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mailman School of Public Health, Columbia University, New York, NY","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013307217","display_name":"Jasmine M. Zain","orcid":"https://orcid.org/0009-0009-0753-1019","observed_orcids":["https://orcid.org/0009-0009-0753-1019"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasmine Zain","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen A. O\u2019Connor","raw_affiliation_strings":["Center for Lymphoid Malignancies, Columbia University, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Columbia University, New York, NY;","institution_ids":["https://openalex.org/I78577930"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":5.4189,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.96067416,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"122","issue":"12","first_page":"2104","last_page":"2113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7095000147819519,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.7095000147819519,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.24289999902248383,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sirtuin-inhibition","display_name":"sirtuin inhibition","score":0.8659999966621399},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.796999990940094},{"id":"https://openalex.org/keywords/bcl6","display_name":"BCL6","score":0.8949999809265137},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8479999899864197},{"id":"https://openalex.org/keywords/histone-deacetylation","display_name":"histone deacetylation","score":0.7910000085830688},{"id":"https://openalex.org/keywords/nicotinamide","display_name":"nicotinamide","score":0.8370000123977661},{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8410000205039978},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.8899999856948853},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8389999866485596}],"concepts":[{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.8909194469451904},{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.7283459901809692},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5811194777488708},{"id":"https://openalex.org/C2777537477","wikidata":"https://www.wikidata.org/wiki/Q17847411","display_name":"BCL6","level":5,"score":0.5029811263084412},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.496905118227005},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4817242920398712},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4717876613140106},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.4624927341938019},{"id":"https://openalex.org/C2776536020","wikidata":"https://www.wikidata.org/wiki/Q21113719","display_name":"Sirtuin 1","level":4,"score":0.4593622386455536},{"id":"https://openalex.org/C2780561631","wikidata":"https://www.wikidata.org/wiki/Q421331","display_name":"Sirtuin","level":4,"score":0.4550919532775879},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44471195340156555},{"id":"https://openalex.org/C2781462825","wikidata":"https://www.wikidata.org/wiki/Q7363205","display_name":"Romidepsin","level":5,"score":0.41474491357803345},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34625110030174255},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33136123418807983},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3216431140899658},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.29875582456588745},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21800988912582397},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10455334186553955},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0995369553565979},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.09363803267478943},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08700606226921082},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.06474193930625916},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C96926380","wikidata":"https://www.wikidata.org/wiki/Q1737968","display_name":"Germinal center","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000107","descriptor_name":"Acetylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012097","descriptor_name":"Repressor Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D037761","descriptor_name":"Sirtuins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2013-02-485441","doi":"https://doi.org/10.1182/blood-2013-02-485441","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2013-02-485441","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:23913470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23913470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1493846190","https://openalex.org/W1607717188","https://openalex.org/W1970400561","https://openalex.org/W1970854602","https://openalex.org/W1976402300","https://openalex.org/W1979816280","https://openalex.org/W1988466148","https://openalex.org/W1988703453","https://openalex.org/W1990011854","https://openalex.org/W1993147091","https://openalex.org/W1995683628","https://openalex.org/W1996212879","https://openalex.org/W2002451995","https://openalex.org/W2004067791","https://openalex.org/W2006885289","https://openalex.org/W2010117150","https://openalex.org/W2017340736","https://openalex.org/W2041057627","https://openalex.org/W2044365745","https://openalex.org/W2049867368","https://openalex.org/W2053767245","https://openalex.org/W2063304153","https://openalex.org/W2069301193","https://openalex.org/W2071115015","https://openalex.org/W2072944938","https://openalex.org/W2076543297","https://openalex.org/W2079003739","https://openalex.org/W2085418901","https://openalex.org/W2087408588","https://openalex.org/W2100972878","https://openalex.org/W2101690600","https://openalex.org/W2107040737","https://openalex.org/W2124595934","https://openalex.org/W2132343700","https://openalex.org/W2133201432","https://openalex.org/W2137189203","https://openalex.org/W2141920998","https://openalex.org/W2147246240","https://openalex.org/W2152006714","https://openalex.org/W2156517973","https://openalex.org/W2160295522","https://openalex.org/W2167990179","https://openalex.org/W2171771895","https://openalex.org/W2536134588","https://openalex.org/W2584782292","https://openalex.org/W7007920516"],"related_works":["https://openalex.org/W2559264071","https://openalex.org/W2563150706","https://openalex.org/W2563459633","https://openalex.org/W2551333542","https://openalex.org/W2546286582","https://openalex.org/W4251330979","https://openalex.org/W2982789465","https://openalex.org/W2992852221","https://openalex.org/W2516032093","https://openalex.org/W2077294887"],"abstract_inverted_index":{"Understanding":[0],"the":[1,20,46,58,71,97,194],"molecular":[2],"pathogenesis":[3],"of":[4,22,74,83,86,104,120,143,171,199],"lymphoma":[5,33,158,177],"has":[6],"led":[7],"to":[8,37,43,78,99,181],"paradigm-changing":[9],"treatment":[10],"opportunities.":[11],"One":[12],"example":[13],"involves":[14],"tailoring":[15],"specific":[16],"agents":[17],"based":[18],"on":[19,193],"cell":[21,122],"origin":[23],"in":[24,127,134,153,203],"aggressive":[25,156,204],"lymphomas.":[26,205],"Germinal":[27],"center":[28],"(GC)-derived":[29],"diffuse":[30],"large":[31],"B-cell":[32,48,157],"(DLBCL)":[34],"is":[35,51,62,76,88,106],"known":[36],"be":[38],"driven":[39,52],"by":[40,53,117],"an":[41],"addiction":[42],"Bcl6,":[44],"whereas":[45],"activated":[47],"(ABC)":[49],"subtype":[50],"nuclear":[54],"factor":[55],"\u03baB.":[56],"In":[57,163],"GC":[59,135],"subtype,":[60],"there":[61],"a":[63,154,164,179],"critical":[64],"inverse":[65],"relationship":[66],"between":[67],"Bcl6":[68,87,145],"and":[69,146,183,185,196],"p53,":[70],"functional":[72],"status":[73],"which":[75],"linked":[77],"each":[79],"transcription":[80],"factor's":[81],"degree":[82],"acetylation.":[84],"Deacetylation":[85],"required":[89],"for":[90,96],"its":[91],"transcriptional":[92],"repressor":[93],"effects":[94],"allowing":[95],"oncogene":[98],"drive":[100],"lymphomagenesis.":[101],"Conversely,":[102],"acetylation":[103,142],"p53":[105],"activating":[107],"when":[108],"class":[109],"III":[110],"deacetylases":[111],"(DACs),":[112],"or":[113,175],"sirtuins,":[114],"are":[115],"inhibited":[116],"niacinamide.":[118],"Treatment":[119],"DLBCL":[121],"lines":[123],"with":[124,129,141,173],"pan-DAC":[125],"inhibitors":[126],"combination":[128,149],"niacinamide":[130],"produces":[131],"synergistic":[132],"cytotoxicity":[133],"over":[136],"ABC":[137],"subtypes.":[138],"This":[139,148,206],"correlated":[140],"both":[144],"p53.":[147],"also":[150],"produced":[151],"remissions":[152],"spontaneous":[155],"mouse":[159],"model":[160],"expressing":[161],"Bcl6.":[162],"phase":[165],"1":[166],"proof-of-principle":[167],"clinical":[168,197],"trial,":[169],"24%":[170],"patients":[172],"relapsed":[174],"refractory":[176],"attained":[178],"response":[180],"vorinostat":[182],"niacinamide,":[184],"57%":[186],"experienced":[187],"disease":[188],"stabilization.":[189],"We":[190],"report":[191],"herein":[192],"preclinical":[195],"activity":[198],"this":[200],"targeted":[201],"strategy":[202],"trial":[207],"was":[208],"registered":[209],"at":[210],"www.clinicaltrials.gov":[211],"as":[212],"#NCT00691210.":[213]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}